USOR 24152 - Ph3 study of ARTEMIDE-GASTRIC01 in combo with pembro FIL gastric cancer

A Randomized, Phase III Study of Rilvegostomig in Combination with Fluoropyrimidine and Trastuzumab Deruxtecan versus Trastuzumab, Chemotherapy, and Pembrolizumab for the First line Treatment of HER2-positive Gastric Cancer.

Disease Types: Gastric

Available at: Arlington Heights, Chicago Resurrection, Niles